Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Takanori SuzukiKentaro MatsuuraYuta SuzukiFumihiro OkumuraYoshihito NaguraSatoshi SobueDaisuke KatoAtsunori KusakabeHiroki KoguchiIzumi HasegawaSho MatoyaTomokatsu MiyakiYoshihide KimuraYoshito TanakaHiromu KondoAtsushi OzasaHayato KawamuraKayoko KunoKei FujiwaraShunsuke NojiriHiromi Kataokanull nullPublished in: Oncology (2024)
PNI-2c is a predictor of prognosis in HCC patients treated with Atez/Bev therapy.